AURA vs DBVT: stock comparison and AI forecast
Aura Biosciences, Inc. (AURA) and Dbv Technologies S.A. (DBVT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AURA Aura Biosciences, Inc.
- Market Cap
- $647M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
DBVT Dbv Technologies S.A.
- Price
- $9.05 -53.5% · 6M
- Market Cap
- $636M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AURA and DBVT have similar market capitalizations ($647M and $636M).
- DBVT carries 0.38 times debt per unit of equity, against 0.10 times for AURA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AURA | DBVT |
|---|---|---|
| Market Cap | $647M | $636M |
| P/B Ratio | 2.05x | 3.77x |
| EPS | $-1.77 | $-0.95 |
| Book Value/Share | $3.04 | $2.68 |
| Revenue/Share | – | $0.07 |
| FCF/Share | $-1.00 | $-3.05 |
Profitability & Margins
| Metric | AURA | DBVT |
|---|---|---|
| ROE | -41.6% | – |
| ROA | -37.6% | – |
| ROIC | -42.0% | – |
| Operating Margin | – | -4204.9% |
| EBT Margin | – | -4175.6% |
| Tax Rate | -0.1% | -0.5% |
Financial Health
| Metric | AURA | DBVT |
|---|---|---|
| Current Ratio | 16.82x | 3.24x |
| D/E Ratio | 0.10x | 0.38x |
| Financial Leverage | 1.10x | – |
| Working Capital | $309M | $131M |
Cash Flow
| Metric | AURA | DBVT |
|---|---|---|
| Operating Cash Flow | -$103M | -$188M |
| Free Cash Flow | -$103M | -$192M |
| Capital Spending | -$340K | -$3M |
| FCF/Sales | – | -4171.1% |
| CapEx/Sales | – | 73.4% |
Operational Efficiency
| Metric | AURA | DBVT |
|---|---|---|
| Fixed Assets Turnover | – | 0.4x |
Income Statement
| Metric | AURA | DBVT |
|---|---|---|
| Total Revenue | – | $5M |
| Operating Income | -$138M | -$235M |
| Net Income | -$131M | – |
| R&D Expense | $103M | $166M |
| SG&A Expense | – | $106M |
Dividend & Shareholder Information
| Metric | AURA | DBVT |
|---|---|---|
| Shares Outstanding | 104M | 63M |
AURA vs DBVT: stock comparison and AI forecast
Which is bigger, AURA or DBVT?
AURA and DBVT have similar market capitalizations ($647M and $636M).
Which one does Intratio's AI model rank higher, AURA or DBVT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.